Telecobalt therapy for malignant lung tumours.
Acta Radiol Ther Phys Biol, 1976/10;15(5):394-400.
Ghilezan N, Milea N, Tamburlini S
PMID: 188306
Abstract
The authors present the results of telecobalt therapy in 194 patients with malignant lung tumours treated between 1967 and 1971. The 3- and 5-year survivals were 9.7 and 5.4% respectively, with an average survival of 15 months. The results obtained depend on the microscopy, the clinical staging and on the irradiation techniques possible; several prognostic groups may be distinguished.
MeSH terms
Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Female; Follow-Up Studies; Gamma Rays; Humans; Lung Neoplasms; Male; Middle Aged; Radioisotope Teletherapy
More resources
EndNote: Download